Kevin A. Grimes

507 total citations
12 papers, 253 citations indexed

About

Kevin A. Grimes is a scholar working on Infectious Diseases, Epidemiology and Oncology. According to data from OpenAlex, Kevin A. Grimes has authored 12 papers receiving a total of 253 indexed citations (citations by other indexed papers that have themselves been cited), including 9 papers in Infectious Diseases, 4 papers in Epidemiology and 3 papers in Oncology. Recurrent topics in Kevin A. Grimes's work include SARS-CoV-2 and COVID-19 Research (5 papers), COVID-19 Clinical Research Studies (4 papers) and Immune responses and vaccinations (3 papers). Kevin A. Grimes is often cited by papers focused on SARS-CoV-2 and COVID-19 Research (5 papers), COVID-19 Clinical Research Studies (4 papers) and Immune responses and vaccinations (3 papers). Kevin A. Grimes collaborates with scholars based in United States and Mexico. Kevin A. Grimes's co-authors include Pablo C. Okhuysen, Stephen M. Rich, Giovanni Widmer, Cynthia L. Chappell, Saul Tzipori, Xiaochuan Feng, R. Mark Ghobrial, Ashish Saharia, Mark J. Hobeika and A. Osama Gaber and has published in prestigious journals such as SHILAP Revista de lepidopterología, Blood and Journal of Clinical Microbiology.

In The Last Decade

Kevin A. Grimes

12 papers receiving 246 citations

Author Peers

Peers are selected by citation overlap in the author's most active subfields. citations · hero ref

Author Last Decade Papers Cites
Kevin A. Grimes 181 71 51 41 40 12 253
Sophie Amrane 150 0.8× 25 0.4× 30 0.6× 21 0.5× 55 1.4× 17 262
Ralph Tayyar 99 0.5× 9 0.1× 139 2.7× 15 0.4× 33 0.8× 18 246
Jianning Tong 258 1.4× 4 0.1× 37 0.7× 26 0.6× 50 1.3× 7 329
Sarah Taimur 185 1.0× 13 0.2× 203 4.0× 12 0.3× 10 0.3× 35 319
Sílvia Capilla 154 0.9× 135 1.9× 37 0.7× 3 0.1× 16 0.4× 18 330
Eva Van den Eynde 125 0.7× 32 0.5× 103 2.0× 6 0.1× 18 0.5× 25 273
M. Asunción Iborra 119 0.7× 76 1.1× 189 3.7× 9 0.2× 8 0.2× 25 330
Mohanad Al‐Obaidi 137 0.8× 21 0.3× 79 1.5× 10 0.2× 11 0.3× 22 187
Paulo Sérgio Ramos de Araújo 100 0.6× 42 0.6× 76 1.5× 14 0.3× 7 0.2× 55 258
Michael Chang 59 0.3× 32 0.5× 55 1.1× 5 0.1× 4 0.1× 23 223

Countries citing papers authored by Kevin A. Grimes

Since Specialization
Citations

This map shows the geographic impact of Kevin A. Grimes's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Kevin A. Grimes with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Kevin A. Grimes more than expected).

Fields of papers citing papers by Kevin A. Grimes

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Kevin A. Grimes. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Kevin A. Grimes. The network helps show where Kevin A. Grimes may publish in the future.

Co-authorship network of co-authors of Kevin A. Grimes

This figure shows the co-authorship network connecting the top 25 collaborators of Kevin A. Grimes. A scholar is included among the top collaborators of Kevin A. Grimes based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Kevin A. Grimes. Kevin A. Grimes is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

12 of 12 papers shown
1.
Adelman, Max W., Ashton A. Connor, Ashish Saharia, et al.. (2023). Bloodstream infections after solid organ transplantation: clinical epidemiology and antimicrobial resistance (2016–21). JAC-Antimicrobial Resistance. 6(1). dlad158–dlad158. 14 indexed citations
2.
Vasileiou, Spyridoula, LaQuisa Hill, Manik Kuvalekar, et al.. (2022). Allogeneic, off-the-shelf, SARS-CoV-2-specific T cells (ALVR109) for the treatment of COVID-19 in high-risk patients. Haematologica. 108(7). 1840–1850. 16 indexed citations
3.
Musick, William L., et al.. (2022). Extensively Drug-Resistant Myroides odoratus in Critically Ill Patients: A Case Series and Literature Review. SHILAP Revista de lepidopterología. 2022. 1–7. 7 indexed citations
4.
Vasileiou, Spyridoula, Manik Kuvalekar, Ayumi Watanabe, et al.. (2021). Allogeneic, Off-the-Shelf, Sars-Cov-2-Specific T Cells to Treat High-Risk Patients with COVID-19. Transplantation and Cellular Therapy. 27(3). S348–S349. 3 indexed citations
5.
Eubank, Taryn A, Constance M. Mobley, Mark J. Hobeika, et al.. (2021). Successful Treatment of Invasive Mucormycosis in Orthotopic Liver Transplant Population. SHILAP Revista de lepidopterología. 2021. 1–7. 6 indexed citations
6.
Vasileiou, Spyridoula, Manik Kuvalekar, Ayumi Watanabe, et al.. (2021). 37. Allogeneic, Off-the-Shelf, SARS-CoV-2-specific T Cells Demonstrate Reactivity Against Emerging Variant Strains. Open Forum Infectious Diseases. 8(Supplement_1). S27–S27. 2 indexed citations
7.
Yi, Stephanie G., A. Rogers, Ashish Saharia, et al.. (2020). Early Experience With COVID-19 and Solid Organ Transplantation at a US High-volume Transplant Center. Transplantation. 104(11). 2208–2214. 81 indexed citations
8.
Vasileiou, Spyridoula, Manik Kuvalekar, Ayumi Watanabe, et al.. (2020). Using Allogeneic, Off-the-Shelf, Sars-Cov-2-Specific T Cells to Treat High Risk Patients with COVID-19. Blood. 136(Supplement 1). 5–5. 3 indexed citations
9.
Balogh, Julius, Sherilyn Gordon Burroughs, Maha Boktour, et al.. (2015). Efficacy and cost‐effectiveness of voriconazole prophylaxis for prevention of invasive aspergillosis in high‐risk liver transplant recipients. Liver Transplantation. 22(2). 163–170. 20 indexed citations
10.
Schlumbrecht, Matthew, Kevin A. Grimes, & Jubilee Brown. (2011). Cytomegalovirus reactivation following chemoradiation for invasive cervical carcinoma. PubMed. 1(1). 22–23. 2 indexed citations
11.
Grimes, Kevin A., Mohamed A. Jamal, Herbert L. DuPont, et al.. (2008). PCR-Based Assay Using Occult Blood Detection Cards for Detection of Diarrheagenic Escherichia coli in Specimens from U.S. Travelers to Mexico with Acute Diarrhea. Journal of Clinical Microbiology. 46(7). 2227–2230. 21 indexed citations
12.
Okhuysen, Pablo C., Stephen M. Rich, Cynthia L. Chappell, et al.. (2002). Infectivity of aCryptosporidium parvumIsolate of Cervine Origin for Healthy Adults and Interferon‐γ Knockout Mice. The Journal of Infectious Diseases. 185(9). 1320–1325. 78 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026